who discovered glp 1 agonists Discovery of GLP-1–Based Drugs for the Treatment of Obesity Evolution of GLP‐1 Receptor Agonists

[DOI] [PMC free article] [PubMed] [Google Scholar] Wilding JPH, STEP 1 Study Group, Batterham RL, Calanna S, Davies M, Gaal LF, Van Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA et al

AS reports consultant fees from, Bayer, Eli Lilly Novo Nordisk and Sankyo, and lecture fees from Bayer, Eli Lilly, Novo Nordisk, and Sanofi-Aventis

Participants were required to have a BMI between 28 and 38 kg/m 2 , to have an HbA1c concentration between 6.5 and 9%

BMJ 386:1645 Bouret SG, Simerly RB (2006) Developmental programming of hypothalamic feeding circuits

[5] Understanding the context is essential for both patients and healthcare professionals